Skip to search formSkip to main contentSkip to account menu

doxacurium

Known as: doxacurium [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (2)

BW A938Udoxacurium chloride
Drug Allergy

Broader (2)

IsoquinolinesNeuromuscular Nondepolarizing Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium.
UNLABELLED Doxacurium's clearance (C1) is markedly decreased in patients with renal failure undergoing kidney transplantation… 
1997
1997
Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients.
OBJECTIVES To determine the optimal dosing of doxacurium as a continuous infusion in neurosurgical patients with traumatic brain… 
1997
1997
Pharmacokinetic–Pharmacodynamic Modeling of Doxacurium: Effect of Input Rate
One of the basic assumptions in pharmacokinetic–pharmacodynamic modeling (PK–PD) is that drug equilibration rate constant between… 
1997
1997
Recovery from Doxacurium Infusion Administered to Produce Immobility for More Than Four Days in Pediatric Patients in the Intensive Care Unit
Doxacurium was administered by titrated infusion to 14 pediatric patients for 4.7-12.3 days after laryngotracheal reconstruction… 
Review
1995
Review
1995
Complications of muscle relaxants
1994
1994
Recovery of mivacurium and doxacurium versus vecuronium in the isolated forearm
To assess rate of biophase recovery, the recovery from neuromuscular block with mivacurium in the isolated forearm was compared… 
1993
1993
Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost?
We compared the pharmacodynamic effects and hospital costs of three long-acting neuromuscular blocking drugs in a prospective… 
1992
1992
Population pharmacodynamics of doxacurium
The nonlinear mixed‐effects modeling (NONMEM) computer program was used to investigate the variability in the duration of… 
1992
1992
Dose‐Response Relations of Doxacuriurn and Its Reversal With Neostigmine in Young Adults and Healthy Elderly Patients
Dose-response relationships for doxacurium and neostigmine were established in 24 young (18–40 yr) and 24 elderly (70–85 yr… 
Highly Cited
1991
Highly Cited
1991
Pharmacokinetics and Pharmacodynamics of Doxacurium in Normal Patients and in Those With Hepatic or Renal Failure
&NA; We determined the pharmacokinetics and duration of action of a bolus dose of doxacurium (15 μg/kg) in 27 patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)